ADGCX
Price
$15.18
Change
-$0.47 (-3.00%)
Updated
Dec 18 closing price
VFINX
Price
$543.37
Change
-$16.51 (-2.95%)
Updated
Dec 18 closing price
Ad is loading...

ADGCX vs VFINX

Header iconADGCX vs VFINX Comparison
Open Charts ADGCX vs VFINXBanner chart's image
AB Core Opportunities C
Price$15.18
Change-$0.47 (-3.00%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$543.37
Change-$16.51 (-2.95%)
VolumeN/A
CapitalizationN/A
ADGCX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ADGCX vs. VFINX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADGCX is a StrongBuy and VFINX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.37T vs. ADGCX (188M). VFINX pays higher dividends than ADGCX: VFINX (1.24) vs ADGCX (0.00). ADGCX was incepted earlier than VFINX: ADGCX (25 years) vs VFINX (48 years). ADGCX is a more actively managed with annual turnover of: 92.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than ADGCX: VFINX (0) vs ADGCX (2500). VFINX annual gain was more profitable for investors over the last year : 27.63 vs. ADGCX (10.21). VFINX return over 5 years is better than : 88.65 vs. ADGCX (-2.61).
ADGCXVFINXADGCX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years48 years-
Gain YTD9.28827.27534%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets188M1.37T0%
Annual Yield % from dividends0.001.24-
Returns for 1 year10.2127.6337%
Returns for 3 years-7.5130.99-24%
Returns for 5 years-2.6188.65-3%
Returns for 10 years-3.63193.62-2%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.090.31
+5.36%
LexinFintech Holdings Ltd
DDOG156.911.09
+0.70%
Datadog
PAR78.060.08
+0.10%
PAR Technology Corp
HRI195.00-4.00
-2.01%
Herc Holdings
BRNS0.92-0.05
-5.26%
Barinthus Biotherapeutics plc